Mutual impact of HIV infection on HIV/tuberculosis co-infection

L. Pehme, P. Viiklepp, A. Altraja (Tartu, Tallinn, Estonia)

Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Session: Tuberculosis and HIV co-infection
Session type: E-Communication Session
Number: 3303
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Pehme, P. Viiklepp, A. Altraja (Tartu, Tallinn, Estonia). Mutual impact of HIV infection on HIV/tuberculosis co-infection. Eur Respir J 2009; 34: Suppl. 53, 3303

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The (in)significance of TB and COVID-19 co-infection
Source: Eur Respir J, 56 (2) 2002105; 10.1183/13993003.02105-2020
Year: 2020



The impact of HIV on tuberculosis recrudescence
Source: Eur Respir J 2004; 24: Suppl. 48, 362s
Year: 2004

Treatment outcomes of MDR-TB and HIV co-infection in Europe
Source: Eur Respir J, 49 (6) 1602363; 10.1183/13993003.02363-2016
Year: 2017



Timing of relapse of tuberculosis in people with co-infection (HIV/TB)
Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Year: 2020


The twin epidemics: HIV / DR-TB co-infection in 2012
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015


Particularities of tuberculosis at children hospitalized with HIV co-infection
Source: Annual Congress 2009 - Tuberculosis at different age groups
Year: 2009

The tuberculosis in patients with HIV and AIDS
Source: Eur Respir J 2007; 30: Suppl. 51, 656s
Year: 2007

Risk factors of drug -induced hepatitis among patients with TB/HIV co-infection
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010

Features of TB/HIV co-infection and treatment outcome
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012

On tuberculosis and COVID-19 co-infection
Source: Eur Respir J, 56 (2) 2002328; 10.1183/13993003.02328-2020
Year: 2020



Multidrug-resistant TB in children with HIV infection
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007


TB situation in Bulgaria – epidemiology, TB-HIV co-infection
Source: Eur Respir J 2006; 28: Suppl. 50, 16s
Year: 2006

Comparative analysis of pneumonia in patients with drug dependence with HIV infection and without HIV.
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Year: 2020


Tuberculosis and HIV co-infection: do we have a surveillance system in Europe?
Source: Eur Respir J 2011; 38: 1258-1260
Year: 2011


Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients
Source: Eur Respir J, 55 (6) 1902383; 10.1183/13993003.02383-2019
Year: 2020



Recurrent tuberculosis among HIV infected persons in Singapore
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017

The global epidemiology of HIV
Source: Eur Respir Monogr 2014; 66: 1-11
Year: 2014


The incidence of MDR-TB in new and retreatment cases of HIV and pulmonary tuberculosis co-infection
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013


Multidrug-resistant TB in children with HIV infection in Romania
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011